MindMaze Therapeutics Holding (CHIX:MMTXZ) Median PS Value: CHF0.00 (As of Jul. 02, 2026)


CHIX:MMTXZ MindMaze Therapeutics Holding SA CHIX:MMTXZ
15 GF Score
Price CHF0.21
! 2 Warning Signs
View Full Analysis

What is MindMaze Therapeutics Holding Median PS Value?

MindMaze Therapeutics Holding CHIX:MMTXZ +4.74% 15 Median PS Value is CHF0.00 as of Jul. 02, 2026. GuruFocus rates CHIX:MMTXZ with a GF Score™ of 15/100. The stock has 2 warning signs investors should review. Among 277 Biotechnology companies, MindMaze Therapeutics Holding ranks worse than 361010.47% on this metric.

This valuation method assumes that the stock valuation will revert to its historical (10-Year) median in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. MindMaze Therapeutics Holding's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was CHF. MindMaze Therapeutics Holding's 10-Year median PS Ratio is . Therefore, the Median PS Value for today is CHF0.00.

As of today (2026-07-02), MindMaze Therapeutics Holding's share price is CHF0.21. MindMaze Therapeutics Holding's Median PS Value is CHF0.00. Therefore, MindMaze Therapeutics Holding's Price to Median PS Value for today is 0.00.

The historical rank and industry rank for MindMaze Therapeutics Holding's Median PS Value or its related term are showing as below:

CHIX:MMTXz's Price-to-Median-PS-Value is not ranked *
in the Biotechnology industry.
Industry Median: 0.63
* Ranked among companies with meaningful Price-to-Median-PS-Value only.

MindMaze Therapeutics Holding  (CHIX:MMTXz) Median PS Value Explanation

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.

MindMaze Therapeutics Holding's Price to Median PS Value for today is calculated as

Price to Median PS Value=Share Price/Median PS Value
=0.21/
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


MindMaze Therapeutics Holding Median PS Value Related Terms


MindMaze Therapeutics Holding Median PS Value Historical Data

* Premium members only.

The historical data trend for MindMaze Therapeutics Holding's Median PS Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MindMaze Therapeutics Holding Median PS Value Chart

MindMaze Therapeutics Holding Annual Data
Trend Dec24 Dec25
Median PS Value
0.00 0.00

MindMaze Therapeutics Holding Semi-Annual Data
Dec24 Dec25
Median PS Value 0.00 0.00

CHIX:MMTXZ vs VRTX, REGN, ALNY: Median PS Value Comparison

For the Biotechnology subindustry, MindMaze Therapeutics Holding's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MindMaze Therapeutics Holding Price-to-Median-PS-Value vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, MindMaze Therapeutics Holding's Price-to-Median-PS-Value distribution charts can be found below:

* The bar in red indicates where MindMaze Therapeutics Holding's Price-to-Median-PS-Value falls into.


CHIX:MMTXZ
15GF Score
MindMaze Therapeutics Holding SA CHIX:MMTXZ
Median PS Value is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

MindMaze Therapeutics Holding Median PS Value Calculation

MindMaze Therapeutics Holding's Median PS Value for today is calculated as

Median PS Value=Revenue per Share (TTM)*10-Year Median PS Ratio
=*
=

10-Year Median PS Ratio is .
For company reported annually, GuruFocus uses latest annual data as the TTM data. MindMaze Therapeutics Holding's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was CHF.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Median PS Value →
What does a Median PS Value of CHF0.00 mean?
MindMaze Therapeutics Holding (CHIX:MMTXZ) has a Median PS Value of CHF0.00 as of Jul. 02, 2026. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on MindMaze Therapeutics Holding and its competitors. According to the industry distribution chart, MindMaze Therapeutics Holding ranks #999999 out of 277 companies in the Biotechnology industry.
Is MindMaze Therapeutics Holding's Median PS Value too high?
MindMaze Therapeutics Holding's current Median PS Value is CHF0.00. Based on the distribution chart, MindMaze Therapeutics Holding ranks #999999 out of 277 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, MindMaze Therapeutics Holding has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does MindMaze Therapeutics Holding's Median PS Value compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, MindMaze Therapeutics Holding ranks #999999 out of 277 companies for Median PS Value. This places MindMaze Therapeutics Holding in the lower half of its industry. The industry median Median PS Value is 0.63. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Median PS Value for a Biotechnology company?
The median Median PS Value among Biotechnology companies is 0.63, based on 277 companies in the industry. Companies in the top quartile (top 25%) have a Median PS Value significantly above this median, while those in the bottom quartile fall well below. However, Median PS Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Median PS Value mean?
A high Median PS Value can signal that a stock is expensive relative to its fundamentals. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on MindMaze Therapeutics Holding and its competitors. For the Biotechnology industry, the median Median PS Value is 0.63 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MindMaze Therapeutics Holding's current Median PS Value is CHF0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MindMaze Therapeutics Holding stock overvalued right now?
MindMaze Therapeutics Holding (CHIX:MMTXZ) has a current Median PS Value of CHF0.00. The current Median PS Value is CHF0.00. MindMaze Therapeutics Holding's overall GF Score™ is 15/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Median PS Value calculated?
Median PS Value is calculated from a company's financial statements. For MindMaze Therapeutics Holding (CHIX:MMTXZ), the current Median PS Value is CHF0.00 as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

MindMaze Therapeutics Holding Business Description

Other Exchanges RLFTY:USAMMTX:Switzerland
Address Avenue de Secheron 15, Geneva, CHE, 1202
MindMaze Therapeutics Holding SA is a Swiss-based, commercial-stage biopharmaceutical and neurotechnology company. The company develops and commercializes digital treatments for neurological diseases and brain disorders. Its technology platform integrates software, sensors, and telehealth, and its solutions are used in clinical and home settings internationally. The company has developed evidence-based, next-generation neurotherapeutics that provide evidence-based motor and cognitive treatments to redefine clinical outcomes in patients with neurological disease and brain disorders. The company also manages Relief's existing portfolio of clinical and commercial biopharmaceutical assets focused on rare dermatological, metabolic, and respiratory diseases.
15GF Score

Get the complete analysis for CHIX:MMTXZ

Median PS Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF0.21
Price